Revised spectrum of mutations in sarcoglycanopathies

Area of Science:

• Genetics and Molecular Biology
• Neurology
• Biochemistry

Background:

• Autosomal recessive limb-girdle muscular dystrophy (AR-LGMD) is a group of inherited muscle disorders.
• Sarcoglycanopathies, caused by mutations in sarcoglycan (SG) genes, are a significant subtype of AR-LGMD.
• Accurate genetic diagnosis is crucial for understanding disease mechanisms and patient management.

Purpose of the Study:

• To delineate the mutation spectrum in alpha-, beta-, gamma-, and delta-sarcoglycan genes in a cohort of AR-LGMD patients.
• To establish an efficient diagnostic strategy combining protein and genetic analyses.
• To identify novel mutations and characterize mutation types in SG genes.

Main Methods:

• Analysis of 69 probands with clinical criteria for AR-LGMD.
• Multiplex western blot analysis of muscle proteins.
• Sequencing of SG genes, multiplex quantitative-fluorescent PCR, and RT-PCR.
• Genotyping and mutation screening.

Main Results:

• Mutations were detected in 57 out of 69 patients.
• Abnormalities in alpha- and gamma-sarcoglycan were observed in 48 patients with muscle biopsies.
• Alpha-SG involvement was found in 55.3% of cases, gamma-SG in 25.5%, and beta-SG in 17%.
• Twenty-five novel mutations were identified, including frequent exonic deletions in alpha- and gamma-SG genes and duplications in beta-SG gene exon 1.
• A comprehensive diagnostic strategy was proposed, suggesting potential involvement of other genes.

Conclusions:

• The study defines the mutation spectrum in SG genes for AR-LGMD.
• Exonic deletions in alpha- and gamma-SG genes and duplications in beta-SG gene exon 1 are significant findings.
• A combined approach of protein analysis and genetic testing offers an efficient diagnostic strategy for sarcoglycanopathies.
• The findings suggest the existence of additional genes implicated in sarcoglycanopathy-like disorders.